| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5537198 | Vaccine | 2017 | 8 Pages | 
Abstract
												Our results suggest that MF59-TIV is effective in reducing several influenza-related outcomes among the elderly, especially hospitalizations due to influenza-related complications.
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												Alexander Domnich, Lucia Arata, Daniela Amicizia, Joan Puig-Barberà, Roberto Gasparini, Donatella Panatto, 
											